Trump administration extends Russian oil sanctions exemption amid surging prices
The Trump administration extended a sanctions exemption on some Russian oil as prices continue to skyrocket in the wake of the U.S.- Israeli war ag...
A new skin cancer drug has been developed using a genetically engineered virus that targets and replicates only cancer cells. That's according to public broadcaster NHK who said that researchers in Japan found that 77.8% of those tested, improved.
The experimental drug, created through collaboration between the University of Tokyo and Shinshu University, is part of a growing field known as 'viral therapy,' in which modified viruses are designed to selectively attack cancer cells.
Professor Todo Toshiki of the University of Tokyo and his team conducted trials on patients with an aggressive form of skin cancer to assess whether the treatment could be effective against other types of cancer as well.
Results showed that seven out of nine patients who received a combination of conventional treatment and the viral therapy improved, highlighting the potential of using both approaches together.
With no serious side effects reported so far, researchers plan to test the treatment on another nine patients to further evaluate its safety and efficacy.
Todo said the approach may offer a new option for patients who do not respond to existing treatments.
“If the treatment can be used for a variety of cancers, it could fundamentally change cancer treatment,” he added.
The past 24 hours of the Russia-Ukraine war have seen a drastic escalation in both aerial bombardment and frontline losses.
Iran reopened the Strait of Hormuz to commercial shipping on Friday (17 April) for the first time since the U.S. and Israel killed Iran's ex-Supreme Leader in air strikes, triggering the Middle East conflict, at the end of February. A U.S. blockade on Iranian ports, however, remains in force.
Russia published addresses of manufacturers allegedly producing drones or components for Ukraine on Wednesday (15 April), warning European countries against plans to step up UAV supplies to Kyiv.
Netflix shares fell sharply on Friday after the streaming group issued a weaker-than-expected outlook and said chairman and co-founder Reed Hastings will step down from the board.
U.S. President Donald Trump says Israeli and Lebanese leaders have agreed to a 10-day ceasefire that includes Hezbollah, raising cautious hopes of a pause in hostilities after weeks of escalating tensions.
A Chinese biotechnology company is stepping up efforts to combine artificial intelligence (AI) with advanced genetic testing in a bid to improve the success rates of in vitro fertilization (IVF), while also tapping into growing demand for fertility services.
Austria’s government on Friday approved plans to introduce a nationwide ban on social media use for children under the age of 14, alongside reforms to upper secondary school curricula aimed at boosting media literacy and Artificial Intelligence (AI) education from the 2027/28 academic year.
The UK Health Security Agency (UKHSA) said that as of Wednesday evening, it has identified six new cases of meningococcal disease in Kent, bringing the total of confirmed or suspected cases to at least 27.
The Scottish Parliament has voted against legalising assisted dying, ending a years-long campaign to make Scotland the first part of the UK to allow the practice.
The war in the Middle East is beginning to disrupt the flow of critical medicines to Gulf countries, raising concerns about the supply of cancer treatments and other temperature-sensitive drugs, according to pharmaceutical industry executives.
You can download the AnewZ application from Play Store and the App Store.
What is your opinion on this topic?
Leave the first comment